Nykode Therapeutics AS (OSL:NYKD) FCF Margin % : -169.05% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nykode Therapeutics AS's Free Cash Flow for the three months ended in Dec. 2024 was kr-128.47 Mil. Nykode Therapeutics AS's Revenue for the three months ended in Dec. 2024 was kr76.00 Mil. Therefore, Nykode Therapeutics AS's FCF Margin % for the quarter that ended in Dec. 2024 was -169.05%.

As of today, Nykode Therapeutics AS's current FCF Yield % is -75.52%.

The historical rank and industry rank for Nykode Therapeutics AS's FCF Margin % or its related term are showing as below:

OSL:NYKD' s FCF Margin % Range Over the Past 10 Years
Min: -48247.29 Med: -458.49 Max: 83.8
Current: -572.99

During the past 8 years, the highest FCF Margin % of Nykode Therapeutics AS was 83.80%. The lowest was -48247.29%. And the median was -458.49%.

OSL:NYKD's FCF Margin % is ranked worse than
70.56% of 1019 companies
in the Biotechnology industry
Industry Median: -144.89 vs OSL:NYKD: -572.99

Nykode Therapeutics AS FCF Margin % Historical Data

The historical data trend for Nykode Therapeutics AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS FCF Margin % Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

83.80

0.84

-326.00

-763.65

-590.98

Nykode Therapeutics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-2,150.45	-1,687.94	-2,413.87	-2,378.61	-169.05

Competitive Comparison of Nykode Therapeutics AS's FCF Margin %

For the Biotechnology subindustry, Nykode Therapeutics AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nykode Therapeutics AS's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nykode Therapeutics AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nykode Therapeutics AS's FCF Margin % falls into.

Save Embed

Nykode Therapeutics AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nykode Therapeutics AS's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-575.506	/	97.382
	=	-590.98 %

Nykode Therapeutics AS's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-128.474	/	75.996
	=	-169.05 %

Nykode Therapeutics AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VACBF:USA 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.

Nykode Therapeutics AS Headlines

No Headlines